Why Palisade Bio Stock Is Soaring Today
Why Palisade Bio Stock Is Soaring Today
Palisade Bio, Inc. (NASDAQ:PALI) shares are trading higher Tuesday after the company announced the completion of its analysis evaluating ex-vivo bioactivation of PALI-2108.
Palisade Bio, Inc.（納斯達克股票代碼：PALI）週二股價走高，此前該公司宣佈完成其分析評估 ex-vivo PALI-2108 的生物活化。
The Details:
細節：
Palisade Bio said the findings demonstrated PALI-2108 exhibited efficient ex-vivo conversion into its active PDE4 inhibitor form in stool samples from both normal healthy volunteers and patients with ulcerative colitis (UC). The assessment showed PALI-2108 was converted into its active PDE4 inhibitor form at a mean rate of 90.1% with conversion steadily increasing over time.
Palisade Bio 表示，研究結果表明 PALI-2108 表現出高效 ex-vivo 在正常健康志願者和潰瘍性結腸炎（UC）患者的糞便樣本中轉化爲其活性PDE4抑制劑形式。評估顯示，PALI-2108 轉化爲其活性 PDE4 抑制劑形式，平均轉化率爲 90.1%，轉化率隨着時間的推移穩步增加。
"The results from this study underscore our confidence in PALI-2108 as a targeted treatment for moderate-to-severe UC," said Dr. Mitch Jones, CMO at Palisade Bio.
Palisade Bio首席營銷官米奇·瓊斯博士說：“這項研究的結果凸顯了我們對 PALI-2108 作爲中度至重度UC的靶向治療的信心。”
"The successful bioactivation of prodrug PALI-2108 into its active PDE4 inhibitor form at consistently high conversion rates over a 24-hour period in stool samples highlights its promise as an innovative therapeutic approach for managing UCl," Jones added.
瓊斯補充說：“在糞便樣本中，前藥 PALI-2108 成功生物活化爲活性 PDE4 抑制劑形式，在 24 小時內保持較高的轉化率，這凸顯了其作爲管理倫敦大學藥的創新治療方法的前景。”
Palisade Bio shares are trending on social media and moving on heavy trading volume Tuesday. According to data from Benzinga Pro, more than 13.2 million shares have already been traded in the session, compared to the stock's 100-day average of less than 192,000 shares.
Palisade Bio的股票在社交媒體上呈上升趨勢，週二交易量居高不下。根據Benzinga Pro的數據，該交易日已經交易了超過1,320萬股股票，而該股的100天平均交易量不到19.2萬股。
Related News: What's Going On With Rivian Automotive Stock?
相關新聞： Rivian Automotive 股票怎麼了？
How To Buy PALI Stock:
如何購買 PALI 股票：
By now you're likely curious about how to participate in the market for Palisade Bio – be it to purchase shares, or even attempt to bet against the company.
到目前爲止，你可能對如何參與Palisade Bio的市場感到好奇——無論是購買股票，還是試圖對該公司下注。
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy 'fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
購買股票通常通過經紀賬戶完成。您可以在此處找到可能的交易平台列表。許多股票允許您購買 “部分股票”，這使您無需購買整股即可擁有部分股票。例如，某些股票，例如伯克希爾·哈撒韋公司或亞馬遜，僅擁有一股股票可能要花費數千美元。但是，如果您只想投資其中的一小部分，經紀公司將允許您這樣做。
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to 'go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
如果你想對一家公司下注，這個過程會更加複雜。您需要訪問期權交易平台或經紀商，該經紀人將允許您 “空頭” 一股股票，將股票借給您。可以在此資源中找到做空股票的過程。否則，如果您的經紀人允許您交易期權，您可以買入看跌期權，也可以以高於當前股票交易價格的行使價賣出看漲期權——無論哪種方式，它都允許您從股價下跌中獲利。
PALI Price Action: According to Benzinga Pro, Palisade Bio shares are up 60.8% at $6.69 at the time of publication Tuesday.
PALI價格走勢：根據Benzinga Pro的數據，在週二發佈時，Palisade Bio的股價上漲了60.8％，至6.69美元。
Image: Myriams-Fotos from Pixabay
圖片：Myriams-Fotos 來自 Pixabay